BioSpace News Archive

Drug Development

Escient Pharmaceuticals Announces Oral Presentation of Data Highlighting the Preclinical Pharmacology of EP262 at the American Academy of Allergy, Asthma and Immunology Annual Meeting

Escient Pharmaceuticals announced the presentation of preclinical data related to the company’s EP262 development program at the American Academy of Allergy, Asthma and Immunology Annual meeting being held in San Antonio, TX, February 24-27, 2023.

February 26, 2023
·
3 min read
Drug Development

Celldex Therapeutics Presents Positive Data from Barzolvolimab Phase 1b Study in Chronic Spontaneous Urticaria at AAAAI 2023

Celldex Therapeutics, Inc. announced updated data from the Company’s Phase 1b clinical trial of barzolvolimab in patients with moderate to severe chronic spontaneous urticaria refractory to antihistamines.

February 26, 2023
·
13 min read
Pharm Country

Mesoblast Financial Results and Corporate Update Webcast - February 27, 2023

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the second quarter ended December 31, 2022.

February 26, 2023
·
2 min read
Genetown

Blueprint Medicines Presents Registrational Data from PIONEER Trial of AYVAKIT® (avapritinib) in Patients with Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting

Blueprint Medicines Corporation announced detailed results from the PIONEER trial of AYVAKIT® in patients with indolent systemic mastocytosis.

February 26, 2023
·
13 min read